JF
ABUS icon

Jump Financial’s Arbutus Biopharma ABUS Stock Holding History

Jump Financial’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$255K Buy
+53,162
New +$233K ﹤0.01% 1744
2023
Q2 		– Sell
-68,974
Closed -$209K – 1750
2023
Q1 		$209K Buy
+68,974
New +$195K 0.01% 1293
2022
Q2 		– Sell
-57,300
Closed -$171K – 1558
2022
Q1 		$171K Sell
57,300
-18,340
-24% -$56.1K 0.01% 1338
2021
Q4 		$294K Buy
+75,640
New +$294K 0.02% 904

Other funds holding ABUS

TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
WCM
Whitefort Capital Management New York $406M AUM 84.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Jump Financial's ABUS Position: Q2 2026 in Review

Jump Financial opened a new position in Arbutus Biopharma (ABUS) in Q2 2026: 53,162 shares worth $255K. The stake represents ﹤0.01% of the portfolio and ranks #1744 among its holdings. This is a return to the name: Jump Financial previously reported a position in ABUS as recently as Q1 2023.

Jump Financial first reported a position in ABUS in Q4 2021 and has held it in 4 quarters since. The position peaked at $294K in Q4 2021. 176 funds tracked by Wall St. Rank hold ABUS as of Q2 2026.

  • Jump Financial held 53,162 shares of Arbutus Biopharma worth $255K as of Q2 2026.
  • Arbutus Biopharma was a new Jump Financial position in Q2 2026.
  • Arbutus Biopharma made up ﹤0.01% of Jump Financial's portfolio in Q2 2026, its #1744 holding.
  • Jump Financial first reported a position in Arbutus Biopharma in Q4 2021 and has held it in 4 quarters since.
  • Jump Financial's Arbutus Biopharma position peaked at $294K in Q4 2021.
  • 176 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.